Expression of a Human IgG4 Antibody, BAB2, with Specificity for the Major Birch Pollen Allergen, Bet v 1 in Escherichia coli: Recombinant BAB2 Fabs Enhance the Allergic Reaction (original ) (raw )Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1
Vincenzo Visco
Journal of immunology (Baltimore, Md. : 1950), 1996
View PDFchevron_right
Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1☆, ☆☆, ★, ★★
Jean-jacques Pin
Journal of Allergy and Clinical Immunology, 1997
View PDFchevron_right
Molecular characterization of human IgG monoclonal antibodies specific for the major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance the anaphylactic reaction
Peter Steinberger
FEBS Letters, 2000
View PDFchevron_right
Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2
Fatima Ferreira
Journal of allergy and …, 1996
View PDFchevron_right
Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG1 and IgG4 against the Major Birch Pollen Allergen Bet v 1
Rodolfo Bianchini
International Journal of Molecular Sciences
View PDFchevron_right
Conversion of grass pollen allergen-specific human IgE into a protective IgG1 antibody
Peter Steinberger
European Journal of Immunology, 2002
View PDFchevron_right
Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2
Fatima Ferreira
Journal of allergy and …, 1996
View PDFchevron_right
Vaccination for birch pollen allergy Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1
Morten Svenson
Molecular Immunology, 2003
View PDFchevron_right
Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1
Guro Gafvelin
International Archives of Allergy and Immunology, 2005
View PDFchevron_right
Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy
Michael Breitenbach
Journal of Experimental Medicine, 1996
View PDFchevron_right
Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for …
Fatima Ferreira
The Journal of …, 1996
View PDFchevron_right
T Cell Epitope-Containing Hypoallergenic Recombinant Fragments of the Major Birch Pollen Allergen, Bet v 1, Induce Blocking Antibodies
FERAH BUDAK
Journal of Immunology, 2000
View PDFchevron_right
Human recombinant antibody fragments specific for a rye-grass pollen allergen: Characterization and potential applications
lol no
Molecular Immunology, 1996
View PDFchevron_right
Dominant Epitopes and Allergic Cross-Reactivity: Complex Formation Between a Fab Fragment of a Monoclonal Murine IgG Antibody and the Major Allergen from Birch Pollen Bet v 1
osman mirza
The Journal of Immunology, 2000
View PDFchevron_right
Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: A quantitative IgE inhibition study with sera from different populations☆☆☆★★★
Hans Grönlund
Journal of Allergy and Clinical Immunology, 1998
View PDFchevron_right
Confirmation of immuno-reactivity of the recombinant major birch pollen allergen Bet v 1a by affinity-CIEF
Andreas Rizzi
ELECTROPHORESIS, 2009
View PDFchevron_right
Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen
Fatima Ferreira
Journal of allergy and …, 1999
View PDFchevron_right
Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a
Fatima Ferreira
Allergy, 2004
View PDFchevron_right
Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies
Barbara Ballmer-weber
Journal of Allergy and Clinical Immunology, 2011
View PDFchevron_right
High-level expression and purification of the major birch pollen allergen, Bet v 1
Fatima Ferreira
Protein expression and …, 1997
View PDFchevron_right
Dominating IgE-Binding Epitope of Bet v 1, the Major Allergen of Birch Pollen, Characterized by X-ray Crystallography and Site-Directed Mutagenesis
osman mirza
The Journal of Immunology, 2003
View PDFchevron_right
Vaccination for birch pollen allergy
Klaus Bendtzen
Molecular Immunology, 2003
View PDFchevron_right
Engineering, Purification and Applications of His-Tagged Recombinant Antibody Fragments with Specificity for the Major Birch Pollen Allergen, Bet v1
Bashar Abdul Alhani
Biological Chemistry, 2000
View PDFchevron_right
Recombinant allergens for immunoblot diagnosis of tree-pollen allergy
Reinhold Hirschwehr
Journal of Allergy and Clinical Immunology, 1991
View PDFchevron_right
Recombinant Bet v 1, the major birch pollen allergen, induces hypersensitivity reactions equal to those induced by natural Bet v 1 in the airways of patients allergic to tree pollen
Reinhold Hirschwehr
Journal of Allergy and Clinical Immunology, 1997
View PDFchevron_right
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
Milena Weber
Journal of Allergy and Clinical Immunology, 2018
View PDFchevron_right
Association of allergic patients’ phenotypes with IgE reactivity to recombinant pollen marker allergens
Ines Swoboda
Allergy, 2010
View PDFchevron_right
Recombinant allergens for immunoblot diagnosis of tree-pollent allergy
Michael Breitenbach
Journal of Allergy and Clinical Immunology, 1991
View PDFchevron_right
Induction and regulation of allergen-specific IgE
Huub Savelkoul
View PDFchevron_right
Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome
Wolf-Meinhard Becker
Clinical & Experimental Allergy, 1999
View PDFchevron_right